Elizabeth Crowley serves as Executive at Celldex Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Elizabeth Crowley has executed 14 insider transactions totaling $3.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 14, 2024 involved exercising options for 30,000 shares valued at $311.4K.
Elizabeth Crowley currently holds 39,074 shares of Celldex Therapeutics, Inc. (CLDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elizabeth Crowley has been a net seller of CLDX stock. They have purchased $0 and sold $3.2M worth of shares.
Elizabeth Crowley's most recent insider trade was on Jun 14, 2024, when they sold 30,000 shares at $10.38 per share.
Get notified when new Form 4 filings are submitted
| $34.87 |
| Discretionary |
| Jun 7, 2024 | CLDX | $77.8K | Option Exercise | 7,500 | $10.38 | Discretionary |
| Jun 7, 2024 | CLDX | $525.9K | Sale | 15,000 | $35.06 | Discretionary |
| Jun 7, 2024 | CLDX | $67.7K | Option Exercise | 7,500 | $9.02 | Discretionary |
| May 30, 2024 | CLDX | $1.3M | Sale | 38,597 | $33.64 | Discretionary |
| May 30, 2024 | CLDX | $95.8K | Option Exercise | 34,445 | $2.78 | Discretionary |
| May 30, 2024 | CLDX | $76.7K | Option Exercise | 8,500 | $9.02 | Discretionary |
| Dec 8, 2021 | CLDX | $160.0K | Sale | 4,000 | $40.00 | Discretionary |
| Dec 8, 2021 | CLDX | $36.1K | Option Exercise | 4,000 | $9.02 | Discretionary |
| Nov 1, 2021 | CLDX | $111.5K | Sale | 2,528 | $44.12 | Discretionary |
| Nov 1, 2021 | CLDX | $23.8K | Option Exercise | 8,555 | $2.78 | Discretionary |
| Nov 1, 2021 | CLDX | $25.9K | Sale | 600 | $43.11 | Discretionary |
| Nov 1, 2021 | CLDX | $49.5K | Sale | 1,189 | $41.62 | Discretionary |